Literature DB >> 20033413

The effects of β-glucan isolated from Pleurotus ostreatus on methotrexate treatment in rats with adjuvant arthritis.

Jozef Rovenský1, M Stančíkova, K Svík, K Bauerová, J Jurčovičová.   

Abstract

The purpose of this study was to evaluate the effect of β-(1,3/1,6)-D: -glucan isolated from Pleurotus ostreatus (β-glucan-PO) on prophylactic treatment of adjuvant arthritis (AA) with methotrexate (MTX) in rats. Groups of rats with AA were treated with methotrexate (1 mg/kg/week), β-glucan-PO (1 mg/kg every second day) or their combination for the period of 28 days from adjuvant application. Body mass, hind paw swelling, arthrogram scores and a level of serum albumin were measured as markers of inflammation and arthritis. Treatment with low dose of MTX significantly inhibited the markers of both inflammation and arthritis. MTX and its combination with β-glucan-PO significantly increased body mass of arthritic rats. β-glucan-PO administered alone significantly decreased both the hind paw swelling and arthritic score. In combination with MTX, β-glucan-PO markedly potentiated the beneficial effects of MTX, which resulted in a more significant reduction of hind paw swelling and arthritic scores. The concentration of albumin in the serum of arthritic controls was significantly lower than in healthy controls. Both MTX alone and the combination treatment with MTX + β-glucan-PO significantly inhibited the decrease in serum albumin. β-Glucan-PO increased the treatment efficacy of basal treatment of AA with MTX.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033413     DOI: 10.1007/s00296-009-1258-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  beta-1,3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures.

Authors:  Geir Hetland; Per Sandven
Journal:  FEMS Immunol Med Microbiol       Date:  2002-03-25

2.  Specificity of membrane complement receptor type three (CR3) for beta-glucans.

Authors:  G D Ross; J A Cain; B L Myones; S L Newman; P J Lachmann
Journal:  Complement       Date:  1987

3.  Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon.

Authors:  P Bobek; S Galbavy
Journal:  Br J Biomed Sci       Date:  2001       Impact factor: 3.829

Review 4.  Molecular basis for invertebrate innate immune recognition of (1-->3)-beta-D-glucan as a pathogen-associated molecular pattern.

Authors:  T Muta
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  Effect of oyster mushroom (Pleurotus ostreatus) on pathological changes in dimethylhydrazine-induced rat colon cancer.

Authors:  P Bobek; S Galbavy; L Ozdin
Journal:  Oncol Rep       Date:  1998 May-Jun       Impact factor: 3.906

6.  Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo.

Authors:  A B Onderdonk; R L Cisneros; P Hinkson; G Ostroff
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 7.  beta-Glucans in promoting health: prevention against mutation and cancer.

Authors:  Mário S Mantovani; Marilanda F Bellini; José Pedro F Angeli; Rodrigo J Oliveira; Ariane F Silva; Lúcia R Ribeiro
Journal:  Mutat Res       Date:  2007-08-03       Impact factor: 2.433

8.  Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis.

Authors:  Abdulkadir Bedirli; Mustafa Kerem; Hatice Pasaoglu; Nalan Akyurek; Tugan Tezcaner; Sehri Elbeg; Leyla Memis; Omer Sakrak
Journal:  Shock       Date:  2007-04       Impact factor: 3.454

9.  A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy.

Authors:  Alan B Weitberg
Journal:  J Exp Clin Cancer Res       Date:  2008-09-19

10.  Dectin-1 is a major beta-glucan receptor on macrophages.

Authors:  Gordon D Brown; Philip R Taylor; Delyth M Reid; Janet A Willment; David L Williams; Luisa Martinez-Pomares; Simon Y C Wong; Siamon Gordon
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

View more
  6 in total

Review 1.  Medicinal mushroom: boon for therapeutic applications.

Authors:  Vivek Kumar Chaturvedi; Sonam Agarwal; Krishna Kumar Gupta; Pramod W Ramteke; M P Singh
Journal:  3 Biotech       Date:  2018-07-23       Impact factor: 2.406

2.  Inhibitory effect of estrogen receptor beta on P2X3 receptors during inflammation in rats.

Authors:  Qian Jiang; Wen-Xin Li; Jia-Run Sun; Tian-Tian Zhu; Juan Fan; Li-Hua Yu; Geoffrey Burnstock; Hua Yang; Bei Ma
Journal:  Purinergic Signal       Date:  2016-11-05       Impact factor: 3.765

3.  Effect of methotrexate on inflammatory cells redistribution in experimental adjuvant arthritis.

Authors:  Lucia Feketeová; Petra Jančová; Petra Moravcová; Andrea Janegová; Katarína Bauerová; Silvester Poništ; Danica Mihalová; Pavol Janega; Pavel Babál
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

Review 4.  Effects of bioactive compounds from Pleurotus mushrooms on COVID-19 risk factors associated with the cardiovascular system.

Authors:  Eduardo Echer Dos Reis; Paulo Cavalheiro Schenkel; Marli Camassola
Journal:  J Integr Med       Date:  2022-07-11

5.  Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress.

Authors:  Katarína Bauerová; Silvester Poništ; Danica Mihalová; František Dráfi; Viera Kuncírová
Journal:  Interdiscip Toxicol       Date:  2011-03

Review 6.  Pleurotus Genus as a Potential Ingredient for Meat Products.

Authors:  Brisa Del Mar Torres-Martínez; Rey David Vargas-Sánchez; Gastón Ramón Torrescano-Urrutia; Martin Esqueda; Javier Germán Rodríguez-Carpena; Juana Fernández-López; Jose Angel Perez-Alvarez; Armida Sánchez-Escalante
Journal:  Foods       Date:  2022-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.